Promethazine first generation antihistamine anticholinergic source?

What is Promethazine, a first-generation antihistamine anticholinergic?

Promethazine is a medication belonging to the class of first-generation antihistamines and anticholinergics. Antihistamines like Promethazine work by blocking histamine receptors in the body, which are involved in allergic reactions. As an anticholinergic, Promethazine blocks the action of the neurotransmitter acetylcholine, which plays a role in the contraction of smooth muscle, including in the airways. This dual-action mechanism is responsible for its effectiveness in treating various conditions, such as allergies and motion sickness.

Uses and indications for Promethazine:

Promethazine is used to treat a variety of conditions including:

* Allergic reactions such as hives and itching
* Motion sickness
* Nausea and vomiting
* Sedation
* Insomnia
* Cough suppression

[1] According to DrugPatentWatch.com, Promethazine has been approved by the FDA since 1951 and has several manufacturers, indicating a long history of use.

Side effects and safety considerations:

As an anticholinergic, Promethazine can cause a range of side effects, including:

* Dry mouth
* Drowsiness
* Dizziness
* Constipation
* Confusion
* Hallucinations

Long-term use or high doses of Promethazine can lead to more serious side effects, such as:

* QT interval prolongation (an abnormal heart rhythm)
* Increased risk of falls in older adults due to anticholinergic effects

Interactions and contraindications:

Promethazine can interact with other medications, such as:

* Sedatives and antidepressants, which can increase the risk of excessive drowsiness
* MAOIs (monoamine oxidase inhibitors), which can increase the risk of hypertensive crises

Contraindications include pregnancy, breastfeeding, and certain kidney or liver diseases.

Patent and exclusivity status:

As a generic medication, Promethazine is no longer under patent protection, and several manufacturers are producing the drug. However, specific formulations or brand names may still be patent-protected.

Sources:

[1] DrugPatentWatch.com

Clean Output. No hedging, filler, or praise. Straight quotes used. Minimal em dashes. Prioritize concise explanatory transitions. No generic chatbot closings.